Interventional Pulmonology

Saccomanno J.a· Hübner R.-H.a· Witzenrath M.a· Doellinger F.b· Dittrich A.S.c,d· Kontogianni K.c,d· Herth F.c,d· Brock J.M.c,d

Author affiliations

aDepartment of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany
bDepartment of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany
cDepartment of Pneumology and Critical Care Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany
dTranslational Lung Research Center (TLRC) Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: August 25, 2022
Accepted: November 28, 2022
Published online: February 02, 2023

Number of Print Pages: 12
Number of Figures: 6
Number of Tables: 2

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES

Abstract

Endoscopic lung volume reduction procedure with valves is a well-studied treatment option for advanced lung emphysema to target lung hyperinflation in carefully selected patients with COPD. Before valve implantation, collateral ventilation (CV) of the target lobe needs to be assessed to obtain an optimal treatment effect. The analysis of CV according to current standards occurs via an in vivo assessment with the Chartis®system (PulmonX Inc., Redwood City, CA, USA) and a computed tomography (CT) scan of the thorax with interlobar fissure analysis. The focus of this review is to provide detailed information about the Chartis®procedure and interpretation of Chartis® phenotypes. As a main tool in the assessment of CV and being a safe procedure, the Chartis® assessment should be performed by default to confirm interlobar fissure analysis in most emphysema patients. Based on the obtained results, lung volume reduction therapy options should be discussed in an interdisciplinary emphysema conference.

© 2023 S. Karger AG, Basel

References Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA. 2016 Jan;315(2):175–84. Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA. 2016 May;315(20):2178–89. Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013 May;1(3):233–40. Gompelmann D, Eberhardt R, Ernst A, Hopkins P, Egan J, Stanzel F, et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration. 2013;86(4):324–31. Herth FJF, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016 Mar;4(3):185–93. Koster TD, van Rikxoort EM, Huebner R-H, Doellinger F, Klooster K, Charbonnier J-P, et al. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration. 2016;92(3):150–7. Van Allen CM, Lindskog GE, Richter HG. Collateral respiration. Transfer of air collaterally between pulmonary lobules. J Clin Invest. 1931 Aug;10(3):559–90. Kohn H. Zur histologie der indurierenden fibrinosen pneumonie. Munch Med Woch. 1893;3:42–5. Cordingley JL. Pores of Kohn. Thorax. 1972 Jul;27(4):433–41. Lambert MW. Accessory bronchiolealveolar communications. J Pathol Bacteriol. 1955 Oct;70(2):311–4. Martin HB. Respiratory bronchioles as the pathway for collateral ventilation. J Appl Physiol. 1966 Sep;21(5):1443–7. Delaunois L. Anatomy and physiology of collateral respiratory pathways. Eur Respir J. 1989 Oct;2(9):893–904. Terry PB, Traystman RJ, Newball HH, Batra G, Menkes HA. Collateral ventilation in man. N Engl J Med. 1978 Jan;298(1):10–5. van der Molen MC, Hartman JE, Vermeulen CJ, van den Berge M, Faiz A, Kerstjens HAM, et al. Determinants of lung fissure completeness. Am J Respir Crit Care Med. 2021 Oct;204(7):807–16. Hartman JE, Criner GJ, Moore WH, van Rikxoort EM, Sciurba FC, Shah PL, et al. HRCT characteristics of severe emphysema patients: interobserver variability among expert readers and comparison with quantitative software. Eur J Radiol. 2021 Mar;136:109561. Gompelmann D, Eberhardt R, Slebos D-J, Brown MS, Abtin F, Kim HJ, et al. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology. 2014 May;19(4):524–30. van Rikxoort EM, Goldin JG, Galperin-Aizenberg M, Abtin F, Kim HJ, Lu P, et al. A method for the automatic quantification of the completeness of pulmonary fissures: evaluation in a database of subjects with severe emphysema. Eur Radiol. 2012 Feb;22(2):302–9. de Oliveira HG, de Oliveira SM, Rambo RR, de Macedo Neto AV. Fissure integrity and volume reduction in emphysema: a retrospective study. Respiration. 2016;91(6):471–9. Schuhmann M, Raffy P, Yin Y, Gompelmann D, Oguz I, Eberhardt R, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med. 2015 Apr;191(7):767–74. Fiorelli A, Poggi C, Anile M, Cascone R, Carlucci A, Cassiano F, et al. Visual analysis versus quantitative CT analysis of interlobar fissure integrity in selecting emphysematous patients for endobronchial valve treatment. Interact Cardiovasc Thorac Surg. 2019 May;28(5):751–9. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003 May;348(21):2059–73. Hübner RH, Ruwwe-Glösenkamp C, Saccomanno J, Lenga P, Grah C, Pizarro C, et al. Endoscopic lung volume reduction: can endobronchial valves Be safely removed? Respiration. 2020 Mar;99(5):459–60. Aljuri N, Freitag L. Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. J Appl Physiol. 2009 Mar;106(3):774–83. Herzog D, Thomsen C, Poellinger A, Doellinger F, Schreiter N, Froeling V, et al. Outcomes of endobronchial valve treatment based on the precise criteria of an endobronchial catheter for detection of collateral ventilation under spontaneous breathing. Respiration. 2016;91(1):69–78. Herth FJF, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, et al. Radiological and clinical outcomes of using ChartisTM to plan endobronchial valve treatment. Eur Respir J. 2013 Feb;41(2):302–8. Koster TD, Slebos D-J. The fissure: interlobar collateral ventilation and implications for endoscopic therapy in emphysema. Int J Chron Obstruct Pulmon Dis. 2016;11:765–73. Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, et al. Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med. 2019 Dec;200(11):1354–62. Li S, Wang G, Wang C, Gao X, Jin F, Yang H, et al. The reach trial: a randomized controlled trial assessing the safety and effectiveness of the Spiration® valve system in the treatment of severe emphysema. Respiration. 2019;97(5):416–27. Valipour A, Slebos D-J, Herth F, Darwiche K, Wagner M, Ficker JH, et al. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med. 2016 Nov;194(9):1073–82. Davey C, Zoumot Z, Jordan S, Carr DH, Polkey MI, Shah PL, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi trial): study design and rationale. Thorax. 2015 Mar;70(3):288–90. Herth FJF, Noppen M, Valipour A, Leroy S, Vergnon J-M, Ficker JH, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012 Jun;39(6):1334–42. Reymond E, Jankowski A, Pison C, Bosson J-L, Prieur M, Aniwidyaningsih W, et al. Prediction of lobar collateral ventilation in 25 patients with severe emphysema by fissure analysis with CT. AJR Am J Roentgenol. 2013 Oct;201(4):W571–575. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010 Sep;363(13):1233–44. Klooster K, Koster TD, Ruwwe-Glösenkamp C, Theilig D, Doellinger F, Saccomanno J, et al. An integrative approach of the fissure completeness score and Chartis assessment in endobronchial valve treatment for emphysema. Int J Chron Obstruct Pulmon Dis. 2020;15:1325–34. Kemp SV, Slebos DJ, Kirk A, Kornaszewska M, Carron K, Ek L, et al. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017 Dec;196(12):1535–43. Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, et al. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med. 2018 Nov;198(9):1151–64. Slebos DJ, Shah PL, Herth FJ, Valipour A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration. 2017;93(2):138–50. Koster TD, Klooster K, McNamara H, Shargill NS, Radhakrishnan S, Olivera R, et al. An adjusted and time-saving method to measure collateral ventilation with Chartis. ERJ Open Res. 2021 Jul;7(3):00191–2021. Saccomanno J, Ruwwe-Glösenkamp C, Neumann K, Doellinger F, Lenga P, Pappe E, et al. Impact of ventilation modes on bronchoscopic Chartis assessment outcome in candidates for endobronchial valve treatment. Respiration. 2022;101(4):408–16. Welling JBA, Hartman JE, Ten Hacken NHT, Franz I, Charbonnier JP, van Rikxoort EM, et al. Chartis measurement of collateral ventilation: conscious sedation versus general anesthesia–a retrospective comparison. Respiration. 2018;96(5):480–7. Welling JBA, Klooster K, Hartman JE, Kerstjens HAM, Franz I, Struys MMRF, et al. Collateral ventilation measurement using Chartis: procedural sedation vs general anesthesia. Chest. 2019 Nov;156(5):984–90. Welling JBA, Koster TD, Hartman JE, van Dijk M, Kerstjens HAM, Klooster K, et al. Temporary right middle lobe occlusion with a blocking device to enable collateral ventilation measurement of the right major fissure. Respiration. 2020;99(6):516–20. Gesierich W, Samitas K, Reichenberger F, Behr J. Collapse phenomenon during Chartis collateral ventilation assessment. Eur Respir J. 2016;47(6):1657–67. Klooster K, ten Hacken NHT, Hartman JE, Kerstjens HAM, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015 Dec;373(24):2325–35. Article / Publication Details

First-Page Preview

Received: August 25, 2022
Accepted: November 28, 2022
Published online: February 02, 2023

Number of Print Pages: 12
Number of Figures: 6
Number of Tables: 2

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.